Compare Align Technology, Inc. (ALGN) vs Goldman Sachs Group Inc (GS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Goldman Sachs Group Inc — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Goldman Sachs Group Inc trades at $1,060.56 (market cap $311.29B). The key difference: Goldman Sachs Group Inc is far larger — about 24.2× Align Technology, Inc.'s market cap, and Goldman Sachs Group Inc pays a 1.71% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | GS | |
|---|---|---|
Market Cap | $12.86B | $311.29B |
Sector | Health | Financials |
52-Week High | $207.19 | $1.11K |
52-Week Low | $124.88 | $700.41 |
Enterprise Value | $11.92B | — |
Volume | — | 2,592,735 |
Dividend Yield | — | 1.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Goldman Sachs (GS) trades at $1,055.18, down 0.07% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $17.55 surpassing expectations of $16.47. Revenue grew to $58.28 billion in 2025, and net income margin improved to 29.89%. Recent news highlights GS's role in leading high-profile IPOs like Anthropic, signaling robust investment banking activity. The stock is near its pivot point of $1,055, with support at $1,045 and resistance at $1,065.
The outlook for GS is positive, driven by earnings momentum and a favorable IPO pipeline, but risks include volatile cash flows and macroeconomic sensitivity. Analyst consensus is a Buy with a price target of $1,080, indicating potential upside. Investors should monitor execution in investment banking and market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Goldman Sachs Group Inc
The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.
Read more on GS →
